Navigation Links
New Jefferson study may redefine how a chronic auto-immune disease is diagnosed
Date:6/10/2009

PHILADELPHIA New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN, led the study which looked at the number of demyelinating features that are needed to differentiate between CIDP, Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and diabetic neuropathy. His research suggests a minimum number of three demyelinating features can be used to positively identify CIDP in a patient. CIDP is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms. It affects about 50,000 people in the United States. The study, available in the current edition of the Journal of Clinical Neuromuscular Disease, may help doctors more effectively diagnose and treat CIDP.

Currently, to make a diagnosis of CIDP, patients undergo nerve conduction studies to determine the number and severity of abnormalities on electrodiagnostic tests. Patients with a specific pattern and number of abnormalities, also know as demyelinating findings, during these studies are determined to have CIDP.

The study involved 26 CIDP patients and a control group of 21 patients, nine ALS patients and 12 diabetic neuropathy patients. The researchers judged the number of demyelinating findings in the CIDP patients that responded to the treatment. They then analyzed the number of features to make the screenings more sensitive. Their findings suggest that with three demyelinating features significantly increased the specificity of the diagnosis of CIDP, but in exchange, the sensitivity was reduced; two features produced a less specific pattern making it difficult to distinguish between CIDP, ALS or diabetic neuropathy, but increased the sensitivity
'/>"/>

Contact: Ed Federico
ed.federico@jefferson.edu
Thomas Jefferson University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Jefferson immunology researchers halt lethal rabies infection in brain
3. Jefferson radiation oncologists use real-time system to plant seeds against cancer
4. Jefferson researchers find personalized interventions key to improving colon cancer screening rates
5. Jefferson researchers uncover new evidence of prolactins possible role in breast cancer
6. MicroRNAs may be key to HIVs ability to hide, evade drugs, Jefferson scientists find
7. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
8. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
9. Jefferson researchers find stem cells in degenerating spinal discs, potential for repair
10. Jefferson researchers show chemotherapy and radiation together extend lung cancer patients lives
11. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AM,Ala.,Nov.24/PRNewswire-FirstCall/--HealthSouthC...ateintheBankofAmericaMerrillLynch2009CreditConfere...rVicePresidentandTreasurerEdFaywillbespeakingonThu...ewebcastliveandwillbeavailableat http://investor.h... AboutHealthSouth ,, HealthSouthisthenation,sl...
(Date:11/24/2009)...at pose choking hazard, are too loud, or contain d...(HealthDay News) -- As the holiday shopping season...toys are still being sold in stores across the Uni... annual Trouble in Toyland report, released Tues...RG). , The report focuses on toys that pose a c...
(Date:11/24/2009)...ibutes to the falls that plague older adults, stud...y News) -- Falls are a leading cause of death amon...chronic pain contributes to those accidents. , ... weakness, and is associated with mobility limitat...hors wrote. , "Chronic pain, no matter how we m...
(Date:11/24/2009)...n example, study finds no added use but higher cos... -- Direct-to-consumer drug ads may contribute to ...at examined sales of the widely used antiplatelet ...ta from 1999 to 2005 for 27 state Medicaid program...opidogrel did not increase people,s use of the dru...
(Date:11/24/2009)...Nov.24/PRNewswire-USNewswire/--Thereisanewgameinto...reduction,offeringpragmaticandrealisticstrategiesw...ed.SpearheadingthismovementisagroupcalledHAMS--Har...AMSisafree-of-charge,lay-ledsupportandinformationa...nstituteonAlcoholAbuseandAlcoholismtellsusthatonly...
Breaking Medicine News(10 mins):Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:Advertising to Consumers May Raise Drug Prices 2Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2
...ernors and Mayors Support Event, ALEXANDRIA, Va.,...ealthcare Decisions Day (NHDD), will be the larges... professionals about,advance healthcare planning.,...are Decisions Day. "All Americans should use April...
...hm-Stecher, assistant professor in food science an... with tiny particles. His latest research project ...ver nanoparticles to improve the safety of the wor...such as microbe-resistant fabrics or non-biofoulin...
...il 10 Hooper Holmes,(Amex: HH ) today announced ... Chief Executive Officer and that Benjamin A. Curr...ctors. Mr. Bubbs, who has been a member of the,Boa...usly been named Chairman-Elect,continues as Chairm...
...fied opinion in Type II examination by independent...LLE, Colo., April 10 GHX has received an,unqualif...of its first Type,II SAS 70 compliance audit. The ...ed GHX,s exchange services, which,enable more than...
...y David Spiegel of Faculty of 1000 Medicine ( www....ween depression care management and survival rates...nt and well-conducted study of the effects of trea... sciences at Stanford University, Spiegel evaluate...
...ntries for the eighth,annual Michael E. DeBakey Jo...iomedical Research (FBR) and named after FBR,s cha...s open to all professional journalists whose repor...Dr. DeBakey,s many inventions and innovations have...
Other Medicine News:Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Iowa State University researcher looks to use nanoparticles for food safety 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 3Health News:GHX Achieves SAS 70 Compliance 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2
(Date:11/24/2009)...rstCall/--NeurocrineBiosciences,Inc.(Nasdaq: NBIX ...ecutiveOfficerofNeurocrineBiosciences,willbepresen...einNewYork. ,, ThelivepresentationtakesplaceTue....m.PacificTime(PT).Thepresentationwillbesimultaneo... http://www.neurocrine.com . ,, Ifyouareunablet...
(Date:11/24/2009)...Newswire/--SatelliteHealthcare,oneofthenation,sfir...ajorsponsorofnephrologyresearch,todayannounceditsf...lahinhisefforttosupporttheSanJosehomelessthisThank...ulcareerasachefforthepast20years.ButNasrallah,slif...edwithEndStageRenalDisease(ESRD).Thediagnosisirrev...
(Date:11/24/2009)...rstCall/--Orexigen®Therapeutics,Inc.(Nasdaq: ...entofobesity,todayannouncedthatonNovember18,2009th...rsgrantedaninducementstockoptiontopurchase200,000s...pointedHeadoftheGlobalContraveProgram. ,, Thest...extentpermittedbylawandhasanexercisepricepersharee...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 1Fate Therapeutics Closes 2430 Million Series B Financing 14844 2Fate Therapeutics Closes 2430 Million Series B Financing 14844 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 4Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3China Medicine Announces Strong Third Quarter 2009 Results 6275 1China Medicine Announces Strong Third Quarter 2009 Results 6275 2China Medicine Announces Strong Third Quarter 2009 Results 6275 3China Medicine Announces Strong Third Quarter 2009 Results 6275 4China Medicine Announces Strong Third Quarter 2009 Results 6275 5China Medicine Announces Strong Third Quarter 2009 Results 6275 6China Medicine Announces Strong Third Quarter 2009 Results 6275 7China Medicine Announces Strong Third Quarter 2009 Results 6275 8China Medicine Announces Strong Third Quarter 2009 Results 6275 9China Medicine Announces Strong Third Quarter 2009 Results 6275 10China Medicine Announces Strong Third Quarter 2009 Results 6275 11China Medicine Announces Strong Third Quarter 2009 Results 6275 12China Medicine Announces Strong Third Quarter 2009 Results 6275 13China Medicine Announces Strong Third Quarter 2009 Results 6275 14China Medicine Announces Strong Third Quarter 2009 Results 6275 15
...., May 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WY...inistration,s (FDA),San Juan District Office has i...ion of its Guayama, Puerto Rico manufacturing,faci... of the site.,The new classification means that an...ed by the Company or do not merit any further,regu...
...taminated with Diethylene Glycol,(DEG) Remains a P..., Md., May 4, 2007-The U.S. Food and Drug,Administ...rs,suppliers, drug repackers, and health professi...gilant in assuring that glycerin, a,sweetener comm...,prescription drug products, is not contaminated w...
Other Medicine Technology:FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2
511 Lightweight Pneumatic Conserver
...Conserver., ,Offers an average 5:1 increase in us...standard cannula. , ,The combination of the OXYMA...ulatory oxygen patients a superior alternative to ...warranty. , ,NOTE: Each model has passed the ...
WAVE 6203
...afts For Insertion Through A 1.0mm Incision., ,... Improved Ergonomics., ,Curved Shafts F...s For Improved Sub-Incisional Flap Purchase., ,...ring Sterilization., ,Reusable, Autoclaveable,...
Medicine Products: